Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$18.3M |
| 2 |
WFT
Weatherford International plc
WFT
|
+$16.5M |
| 3 |
ICL Group
ICL
|
+$11.3M |
| 4 |
Liberty Media Series C
FWONK
|
+$9.18M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$6.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$23.7M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$23.5M |
| 3 |
ExxonMobil
XOM
|
+$11.1M |
| 4 |
IBM
IBM
|
+$8.88M |
| 5 |
HSH
HILLSHIRE BRANDS CO
HSH
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.81% |
| 2 | Technology | 13.76% |
| 3 | Energy | 11.48% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Staples | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
L3Harris
LHX
$53.6B
| $6.78M | 0.03% |
102,146
-1,900
| -2% | -$134K |
|
552
Oceaneering
OII
$5.06B
| $6.75M | 0.03% |
103,600
-1,900
| -2% | -$131K |
|
|
ANSS
553
DELISTED
Ansys
ANSS
| $6.72M | 0.03% |
88,800
-1,400
| -2% | -$110K |
|
|
TW
554
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $6.72M | 0.03% |
67,500
-1,200
| -2% | -$127K |
|
|
GAS
555
DELISTED
AGL Resources Inc
GAS
| $6.71M | 0.03% |
130,800
-1,900
| -1% | -$100K |
|
|
SPLK
556
DELISTED
Splunk Inc
SPLK
| $6.7M | 0.03% |
121,061
+2,200
| +2% | +$110K |
|
|
CNQR
557
DELISTED
CONCUR TECHNOLOGIES INC
CNQR
| $6.68M | 0.03% |
52,700
-600
| -1% | -$60.9K |
|
|
MWV
558
DELISTED
MEADWESTVACO CORP
MWV
| $6.67M | 0.03% |
162,925
-7,200
| -4% | -$308K |
|
559
RPM International
RPM
$15B
| $6.67M | 0.03% |
145,600
-3,000
| -2% | -$138K |
|
560
T-Mobile US
TMUS
$195B
| $6.66M | 0.03% |
230,824
-3,800
| -2% | -$117K |
|
561
Alkermes
ALKS
$8.33B
| $6.65M | 0.03% |
155,100
-2,700
| -2% | -$121K |
|
562
ResMed
RMD
$32.1B
| $6.65M | 0.03% |
134,900
-3,200
| -2% | -$163K |
|
563
Idexx Laboratories
IDXX
$46.8B
| $6.63M | 0.03% |
112,600
-2,400
| -2% | -$152K |
|
564
VeriSign
VRSN
$26.5B
| $6.63M | 0.03% |
120,330
-3,500
| -3% | -$189K |
|
565
Globe Life
GL
$14.2B
| $6.63M | 0.03% |
126,628
-2,900
| -2% | -$157K |
|
|
PCL
566
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $6.63M | 0.03% |
169,829
-2,800
| -2% | -$117K |
|
567
Fidelity National Financial
FNF
$13B
| $6.62M | 0.03% |
343,906
-80,764
| -19% | -$1.56M |
|
|
RKT
568
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $6.59M | 0.03% |
138,536
-1,000
| -0.7% | -$49.6K |
|
569
Williams-Sonoma
WSM
$29.7B
| $6.58M | 0.03% |
197,600
-3,800
| -2% | -$132K |
|
570
UDR
UDR
$12B
| $6.57M | 0.03% |
241,100
-4,000
| -2% | -$116K |
|
571
Kirby Corp
KEX
$6.99B
| $6.56M | 0.03% |
55,700
-1,200
| -2% | -$143K |
|
572
Puma Biotechnology
PBYI
$456M
| $6.54M | 0.03% |
27,400
-500
| -2% | -$103K |
|
573
United Therapeutics
UTHR
$22.6B
| $6.51M | 0.03% |
50,600
-3,000
| -6% | -$309K |
|
574
Darden Restaurants
DRI
$24.9B
| $6.5M | 0.02% |
141,225
-1,790
| -1% | -$75.6K |
|
575
Robert Half
RHI
$4.32B
| $6.46M | 0.02% |
131,738
-2,200
| -2% | -$109K |
|
Similar funds
Swiss National Bank's Q3 2014 Portfolio in Review
As of Q3 2014, Swiss National Bank held 2,547 positions worth $26.1B, down 3.5% from $27B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 1.3%. Swiss National Bank opened 15 new positions and exited 18, leaving the 2,547-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Energy.
- Swiss National Bank's largest Q3 2014 buy was Weatherford International plc: 735,946 shares worth $15.3M.
- Swiss National Bank added most to Allergan plc in Q3 2014, an estimated $18.3M increase.
- Swiss National Bank's biggest Q3 2014 reduction was Apple, cutting an estimated $23.7M.
- Swiss National Bank fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $23.5M.
- Swiss National Bank's ten largest holdings make up 14% of its $26.1B portfolio in Q3 2014.
- Swiss National Bank opened 15 new positions and closed 18 in Q3 2014.
- Swiss National Bank's portfolio value fell 3.5% quarter-over-quarter to $26.1B.
Based on Swiss National Bank's 13F filing for Q3 2014, filed 4 Nov 2014.